The in vivo inhibitory function of the MHC-I α3 domain-CD8α interaction

Area of Science:

• Immunology
• Cellular Biology
• Molecular Interactions

Background:

• The Major Histocompatibility Complex Class I (MHC-I) α3 domain-CD8α interaction is traditionally viewed as a co-stimulatory signal enhancing T cell receptor (TCR) signaling.
• Its precise role in mature peripheral CD8+ T cells in vivo is not fully understood.

Purpose of the Study:

• To investigate the physiological function of the MHC-I α3 domain-CD8α interaction in peripheral CD8+ T cells.
• To determine if this interaction plays an inhibitory role in T cell activation and tolerance.

Main Methods:

• Antibody-mediated disruption of the MHC-I α3 domain-CD8α interaction.
• Analysis of peripheral CD8+ T cell activation and survival.
• Assessment of antigen-induced T cell activation thresholds.
• Utilizing peptide-induced OT-I T cell anergy models with blockade of specific MHC-I α3 domains (H-2D^b, H-2K^b).

Main Results:

• Disruption of the MHC-I α3 domain-CD8α interaction led to spontaneous peripheral CD8+ T cell activation without affecting survival.
• The threshold for antigen-induced T cell activation was lowered, and responsiveness was enhanced.
• Blocking H-2D^b or H-2K^b α3 domain interactions prevented OT-I T cell anergy and restored responsiveness.
• Blockade of H-2K^b α3 domain enhanced OT-I responses even when disrupting the positive co-receptor interaction.

Conclusions:

• The MHC-I α3 domain-CD8α interaction functions as a bidirectional pathway with a previously unrecognized inhibitory role.
• This interaction tonically restrains peripheral CD8+ T cell activation and maintains T cell tolerance.
• Targeting the MHC-I α3 domain-CD8α axis could be a strategy to reverse T cell tolerance and boost anti-tumor or anti-viral immunity.